Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already declare readOnly/openWorld/idempotent, but the description goes far beyond them by disclosing graceful degradation, the figi_candidates ambiguity behavior, the explicit unresolved list, internal cascading lookups, and ownership data when LEI resolves. No statement contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness2/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is one massive wall of text with long parenthetical asides and repetitive query-phrasing examples. It is front-loaded enough to state purpose early, but the content would be far more readable as bullets or short sections. It is functional but not concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description thoroughly covers return values and edge cases: identifiers with source labels, unresolved, figi_candidates, RxCUI plus ingredient/brand and citation, and fallback behavior. It also covers ownership children, non-US issuers, and exact input expectations, so nothing needed to call it correctly is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, yet the description adds substantial meaning: accepted input forms (ticker, CIK, ISIN, name), the ISIN-to-LEI mapping flow, and the warning to pass the entity name only rather than the full noun phrase. These details turn the generic 'value' parameter into a precisely understood input.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific action—'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input'—and reinforces it with concrete examples like ticker, CIK, LEI, and RxCUI. It clearly distinguishes itself from profile or research tools by emphasizing that its output is identifiers needed by other tools. The core purpose is unmistakable even though the description is long.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It contains the explicit directive 'Use FIRST whenever you have a name but need an ID,' which gives clear when-to-use guidance. The supported types and the bond/issuer warning add valuable usage context. However, it never names an alternative tool or states when not to use it, so it falls just short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

The set contains multiple overlapping families: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all answer natural-language data questions, while five polymarket tools and ai_visibility_check/scan_competitor_ai_presence further blur boundaries. The lengthy descriptions help, but an agent will still face genuinely ambiguous selection decisions across these clusters.

Naming Consistency2/5

Tool names mix verb-first patterns (find_stations, validate_claim), domain-first names (polymarket_edges, entity_profile), and brand-prefixed meta tools (pipeworx_trending, pipeworx_feedback). Snake_case is consistent, but there is no predictable verb_noun convention across the set, making the overall naming scheme feel more like a platform catalog than a coherent API.

Tool Count2/5

At 34 tools, this is too many for a well-scoped server, and most of the surface (prediction markets, AI visibility, npm scanning, llms.txt generation) is unrelated to the server's stated Meteostat identity. The count is driven by broad meta wrappers and overlapping data-access aggregates rather than a focused domain model.

Completeness2/5

For a server named Meteostat, the weather surface is notably incomplete: find_stations plus get_daily_history and get_monthly_normals covers stations, daily records, and normals, but there is no current-conditions, forecast, or hourly-history tool even though hourly availability is mentioned in station inventories. The rest of the set is a broad data-research layer, but it does not form a complete lifecycle for any single resource.